Federal contract award

75N90025P00043

CELLEX USA KITS NEEDED FOR EMERGENT EXTRACORPOREAL PHOTOPHERESIS (ECP) PROCEDURES FOR CLINICAL CENTER PATIENT CARE. THERAKOS INC:1232217 [25-000552]

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH - CC
NAICS325413 — In-Vitro Diagnostic Substance Manufacturing
PSC6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$44.4K
Current contract value$44.4K
Potential contract value / ceiling$44.4K
Start dateOct 23, 2024
Current end dateNov 22, 2024
Potential end dateNov 22, 2024
Latest award activityOct 23, 2024
Source loadedAug 15, 2026

Funding and modification history

Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Oct 23, 20240$44.4KCELLEX USA KITS NEEDED FOR EMERGENT EXTRACORPOREAL PHOTOPHERESIS (ECP) PROCEDURES FOR CLINICAL CENTER PATIENT CARE. THERAKOS INC:1232217 [25-000552]

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Tasha LoweContactlowet2@mail.nih.gov
3014026147
SourceOct 10, 2024

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.